THROMBOLEX Announces Interim RAPID-PE Results Showing Favorable Safety and Reproducible Multicenter Results in Acute Pulmonary Embolism
Mechanically channeled thrombolysis procedure disrupts and dissolves thrombus in a single on-the-table session
Independent industry coverage
FDA • MedTech • Biotechnology • Healthcare Business
Medical Device News and MedTech Industry News
Stay informed with the latest medical device news and developments shaping the global MedTech industry. Medical Device News Magazine delivers coverage of innovative medical technologies, FDA approvals and clearances, clinical trials, product launches, and emerging technologies transforming patient care.
Explore news and insights from medical device manufacturers, healthcare technology companies, researchers, and industry leaders. From advances in medical imaging and artificial intelligence to regulatory developments, funding, and acquisitions, our coverage helps healthcare professionals, industry executives, and investors stay informed about the evolving medical device landscape.
Mechanically channeled thrombolysis procedure disrupts and dissolves thrombus in a single on-the-table session
FDA clearance and CE Mark for latest Affera™ Prism-2 Mapping Software expand cardiac mapping capabilities. CE Mark for PulseSelect ProxBox™ Adapter with Proximity Indicator software adds real-time tissue proximity feedback
colimiR-3D, a novel microRNA-based blood test, is designed to enable earlier intervention and personalized management of adolescent idiopathic scoliosis based on progression risk

Fewer people on intake, faster turnaround, and no lost cases: Relu’s new automation captures and centralises every scan and Rx from every source within a minute of arrival
Heraeus Medical has expanded its portfolio with the strategic business area ‘resorbable biomaterials’. With this step, the company is continuing its global growth strategy and strengthens its research and development activities for orthopaedic and trauma care
Collaboration with AAV-specialist CDMO will support scalable production of EPY201 for focal refractory epilepsy affecting 10 million people
Molecular Instruments® (MI), founded by the inventor of HCR™ technology, today announced the availability of HCR™ Gold IF on Biocare Medical’s ONCORE Pro X, a

Brings Together Oncology, Inflammation and Research Data. Science Teams to Foster Scientific Collaboration –
– One of Three Foster City Projects Supporting Gilead’s $32 Billion U.S. Investment and 3,000 High-Quality Domestic Jobs.

The ROADSAVER Stent System is a next-generation design featuring an innovative, dual-layer nitinol micromesh construction. The outer self-expanding nitinol scaffold provides strength and flexibility, while the inner micromesh layer serves as a continuous embolic barrier – helping to contain plaque against the vessel wall and minimize distal embolization during and after the procedure. Read what our expert has to say:

Medical devices have evolved to the point where they no longer operate as standalone products. As these products become more connected, materiovigilance, the process of monitoring and evaluating the safety and performance of medical devices after they reach the market, is becoming increasingly complex.

Nuwellis is building toward that future by advancing a platform that connects precision ultrafiltration, monitoring, pediatric innovation, and data-informed decision-making
By Yuri Nikolsky, Ph.D., D.A.B.R.M. University of Sharjah, Department of Medicine. University City, Sharjah, UAE. ynikolsky@sharjah.ac.ae
Acquisition advances Leica Biosystems’ end-to-end anatomic pathology ecosystem, expanding integrated solutions that help laboratories move from sample to answer with speed and confidence for the clinicians and patients who depend on them
To Advance U.S. Pivotal Trial for Novel Through-the-Scope Type 2 Diabetes Procedure
Since launching in 2021, Angle Health has emerged as the leading alternative to traditional health insurance plans for small businesses nationwide, now serving more than 5,000 employers, offering customized health plans in 47 states, and delivering four consecutive quarters of profitability
Combination creates a scaled U.S. advanced therapies CDMO with broader technical expertise and capabilities from early development through commercial supply

Mobile platform combines smartphone technology, a proprietary light-occluding headset, and AI-assisted software to capture and analyze nystagmus without complex equipment
Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received tentative approval from the United
New addition to rectal spacing portfolio offers flexible hydrogel placement, CT visibility and single-syringe delivery
The designation covers hospitalized newborns and infants from birth to less than 2 years of age, a population for which no insulin dosing recommendation software has been FDA-cleared
An additional peer-reviewed study also set the first clinical significance threshold for essential tremor scores, a bar Felix’s one-year data clear by more than 50%
Mechanically channeled thrombolysis procedure disrupts and dissolves thrombus in a single on-the-table session
Fannin-founded Goldenrod Therapeutics and UT Health San Antonio’s Glenn Biggs Institute are evaluating the investigational PDE4 inhibitor in preclinical models of Alzheimer’s disease
Preclinical study evaluates the safety of laser treatments used to lower intraocular pressure in patients with glaucoma using a rabbit model
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced that the company has appointed Robert Plenge MD., Ph.D., to the company’s Board of Directors, effective September 10, 2026.

Perry Ann Reed succeeds Steve Schnall, who will retire Sept. 30 after 43 years at Phoenix Children’s
Appointments Support Accelerated Trial Enrollment, Market Development,
Scalability, and Future Commercialization
Alkhouli to lead journal through a rapidly evolving era of cardiovascular care

Dr. Vani Sabesan is the only surgeon south of Orlando offering the INHANCE INTACT™ subscapularis-sparing approach to shoulder replacement
The procedure is led by transplant surgeon, Seung Lee, M.D., Ph.D., who performs both living donor nephrectomies and recipient transplantations using this advanced minimally invasive approach